However, it has previously been shown that elevated preoperative CRP is associated with poorer cancer-specific prognosis in patients with colorectal cancer from both centres.6,15 Here, the endpoint of overall survival was chosen to account for potential institutional differences in follow-up protocols and attainment of mortality data. This evidence concerns the gene CRP and cancer.